GlassScriptPhysician profile
Kelly Ryan
NPI 1548963861
$3,334.11
in general payments reported to CMS, 2019-2025
20 companies · $1,178 in 2025
The $1,178 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $724 · 2024: $1,432 · 2025: $1,178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,334.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $939.58 | 2024-2025 | Grafix, Grafix Pl, Oasis |
| Astrazeneca Pharmaceuticals LP | $678.92 | 2023-2025 | Airsupra, Fasenra, Farxiga |
| Organogenesis INC. | $208.45 | 2024-2025 | Affinity, Puraply Wound Matrix, Apligraf |
| Integra Lifesciences Corporation | $163.84 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Next Science LLC | $143.60 | 2024 | Surgx, Blastx, Xperience |
| Xeris Pharmaceuticals, INC. | $135.00 | 2025 | Gvoke Hypopen |
| Gilead Sciences, INC. | $125.00 | 2023 | Epclusa |
| Novo Nordisk INC | $120.97 | 2023 | Wegovy |
| Neurelis, INC. | $118.59 | 2023 | Valtoco |
| Pfizer INC. | $117.54 | 2023 | |
| Alexion Pharmaceuticals, INC. | $115.04 | 2024 | |
| Rigel Pharmaceuticals, INC. | $105.00 | 2024 | Tavalisse, Rezlidhia |
| Kyowa Kirin, INC. | $104.17 | 2025 | |
| Molnlycke Health Care US, LLC | $59.59 | 2023 | Mepilex Border Sacrum, Exufiber Ag+, Mepilex Border Flex |
| Bsn Medical INC | $57.98 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $50.00 | 2023 | |
| Hollister Incorporated | $32.68 | 2025 | Premier, New Image |
| Urgo Medical North America, LLC | $20.50 | 2024 | Urgoclean Ag |
| Solventum Corporation | $19.74 | 2024 | Activ.A.C. |
| Kci USA, INC. | $17.92 | 2023 | Promogran Prisma, V.A.C. Dermatac, Kerramax Care |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.